NAOX Technologies

🚀 EEG is leaving the hospital. Meet us at WIRED Health. 🧠⚡️ On April 16th, NAOX Technologies takes the stage (and the floor) at WIRED Health London to showcase the next frontier of neurotechnology: Ear-EEG. Why does this matter?  Traditional EEG is cumbersome. Our technology makes it invisible.  By capturing brain signals directly from the ear canal, we are enabling continuous, comfortable, and clinical-grade data collection for epilepsy, sleep, and beyond. Coming off our recent FDA 510(k) clearance, we can’t wait to demonstrate how we’re turning standard earbuds into powerful medical tools. Will you be in London? Let’s connect and talk about the future of the "Quantified Self." 📅 April 16  📍 London at Outernet London 🚀 Let’s reshape healthcare together. Click "+Follow" on our LinkedIn page to stay updated on our journey to AES 2025 and beyond! www.naox.tech https://health.wired.com #NeuroTech #WiredHealth2026 #FutureOfHealth #Wearables #Startup #LondonEvents #NAOXLink #earEEG

🚀 Exciting News: NAOX to present new clinical data at AI in Epilepsy & Neurological Disorders Conference! In collaboration with our academic partners (Laboratoire d’Imagerie Biomédicale, Sorbonne Université Paris, Department of Biomedical Engineering, Universidad de los Andes - Colombia, and Hôpital Fondation Adolphe de Rothschild, Paris, France), we are proud to share our latest work on the automatic detection of interictal epileptiform discharges (IEDs) using In-ear EEG technology and AI algorithms. The Study: To validate our approach, we analyzed over 4,450 IEDs recorded synchronously via scalp EEG and our proprietary In-ear EEG solution. Our findings demonstrate the power of combining AI with discreet wearable sensors to detect biomarkers of epilepsy with high precision. 📍 Where: San Juan, Puerto Rico  📅 When: March 16-19, 2026 Poster title: "Automatic detection of interictal epileptiform discharges in In-ear EEG", presented by Eugénie Dessevres. Join us at the congress to explore how NAOX Technologies is transitioning neuro-diagnostics from the clinic to the home. https://lnkd.in/ecACWGJK https://www.naox.tech #AI #Epilepsy #MedTech #DigitalHealth #ClinicalResearch #NAOX

🇺🇸 FDA Cleared. 🌍 ISO 13485 Certified. We are just getting started. We are proud to share that following our FDA Clearance in November 2025, NAOX Technologies is now ISO 13485 Certified by Bureau Veritas Group as of January 2026! This isn't just a badge on the wall; it’s a strategic leap forward: 🇺🇸QMSR Ready: We are perfectly timed for the FDA’s adoption of ISO 13485 standards arriving this February 2, 2026. 🇪🇺EU Pathway: The road is now paved for the CE Mark (Class IIa) of our NAOX in-earEEG. Huge congratulations to the entire team for this collective win, with special recognition to Hugo Cuong DINH (CEO), Stephane Mazet (CPQO) and Rudy Carvalho for driving our quality vision. 🚀The future of in-ear EEG is safe, compliant, and global. 🚀 Click “+Follow” to stay tuned for more updates on this exciting journey! www.naox.tech #MedTech #EEG #ISO13485 #Milestone #HealthTech #NAOX #TeamWork #EEG #QMSR

🧠 Two weeks after CES, we’re still overwhelmed by the response. Over the past days, NAOX Technologies has been featured across leading tech, health and industry media around the world, with more than 225M in total media reach covering the launch of NAOX LINK, the world’s first FDA-cleared in-ear EEG, and the unveiling of NAOX WAVE, our EEG solution for earables manufacturers. 👏 We want to sincerely thank the journalists and editors who took the time to understand our technology and the broader challenge we’re tackling: bringing brain health out of the hospital and into real life. See Fierce Biotech: https://lnkd.in/gjEDWav2 See Engadget: https://lnkd.in/eW_2uUrV Beyond the media coverage, CES was also an intense week of deep technical and product discussions in our suite, with partners exploring how in-ear EEG could shape the next generation of medical and consumer devices. If we didn’t get a chance to connect in Las Vegas, feel free to reach out. The momentum around brain health is just getting started, and we’re excited about what comes next. Stay tuned! #CES2026 #BrainHealth #EEG #Neurotechnology #MedTech #Wearables #HealthTech

🧠 Today marks a major milestone for NaoX Technologies! We’re proud to announce that NAOX Technologies LINK (NX01) has received FDA 510(k) clearance, making it the world’s first FDA-cleared in-ear EEG designed for use in healthcare and home environments. For decades, most EEG were confined to hospitals, complex setups, and short recordings. With NAOX LINK, clinicians and researchers can now easily access clinical-grade brain signals in real-world conditions, enabling longer-duration monitoring beyond traditional clinical workflows. At CES 2026, we are also unveiling NAOX WAVE, our consumer EEG platform designed for non-diagnostic brain-signal awareness in everyday devices. Built on years of medical-grade EEG expertise, NAOX WAVE lays the foundation for bringing credible brain-health insights into the next generation of earbuds. Brain health is one of the biggest unaddressed health challenges of our century. With NAOX LINK and NAOX WAVE, we are building the bridge between clinical neuroscience today and consumer brain-health technology tomorrow. 📍 Meet us at CES 2026 🌐 Learn more: www.naox.tech #FDA #EEG #BrainHealth #Neurotechnology #CES2026 #DigitalHealth #Wearables #MedTech #HealthTech

🚀 Big News! NaoX Technologies is Heading to AES 2025 in Atlanta! We're thrilled to announce that NaoX Technologies will be showcasing our groundbreaking ear-EEG technology at the American Epilepsy Society Annual Meeting (AES 2025) in Atlanta, from December 5-9th! Come meet our team at Booth #1031 to get a first-hand look at how our innovative ear-electroencephalography (ear-EEG) is set to impact long-term #EEG recordings. This breakthrough isn't just about innovation: it's about making crucial brain activity monitoring more accessible than ever, facilitating valuable real-world and at-home long recordings that are both insightful for physicians and more comfortable for patients. 🧠 Our dedicated team will be on-site, eager to discuss this revolutionary technology. Discover its potential applications and how it can bring significant advancements to your research and clinical practice. Don't miss this window to get a glimpse of the future of #EpilepsyDiagnostics and #PatientMonitoring! Click "+Follow" on our LinkedIn page to stay updated on our journey to AES 2025 and beyond! www.naox.tech #NaoX #AES2025 #EEG #EarEEG #Epilepsy #Neuroscience #MedTech #Innovation #HealthcareTechnology #BrainHealth #Atlanta #4PMedecine

Partnering for Progress: NAOX Joins the Epilepsy Foundation's dtRRE We're thrilled to share that we've officially joined the Epilepsy Foundation's Diagnostics and Tracking Research Roundtable (dtRRE). This partnership is a significant step forward in our mission to improve diagnostics and patient care.  By collaborating with this group of industry leaders, researchers, clinicians, regulators, payers, and patients, we will help improve patient pathways, speed up diagnoses, and bridge the gap between large cities and more remote areas. A special thanks to Caitlin Grzeskowiak PhD and Dr. Jacqueline French (pictured here with NAOX two co-founders Hugo Cuong DINH and Michel LE VAN QUYEN) for inviting us to be part of this collaborative effort. We're honored to work alongside the incredible team at the Epilepsy Foundation and are excited to make a real impact together. Don't miss the next post—click "+Follow" to stay updated. www.naox.tech #Epilepsy #Innovation #EEG #earEEG #MedTech #AccessCare #4PMedecine #MedTech #Telemedecine #Neurophysiology #Neurology

🧠 Une nouvelle recherche passionnante : Dépister l'épilepsie nocturne chez les patients atteints d'Alzheimer grâce à l'EEG auriculaire NaoX Grâce à France Alzheimer et le soutien que l’Association apporte aux projets ambitieux et novateurs, nous sommes ravis d'annoncer le lancement d'un projet de recherche majeur qui pourrait révolutionner la prise en charge de la maladie d'Alzheimer (MA). Deux grands hôpitaux parisiens unissent leurs forces pour explorer une problématique très sous-estimée : la fréquence de l'épilepsie du lobe temporal pendant le sommeil chez les patients atteints d'Alzheimer. Les premières études suggèrent que cette forme silencieuse d'épilepsie pourrait toucher 30% ou plus des personnes atteintes de la maladie et accélérer de manière significative leur déclin cognitif. Imaginez l'impact si nous pouvions facilement identifier et traiter ce phénomène ! Cette recherche fondamentale explorera le potentiel de l'EEG auriculaire NaoX, un dispositif innovant, pour devenir le premier outil de dépistage de cette épilepsie silencieuse chez les patients atteints d'Alzheimer pendant leur sommeil. Cette approche novatrice pourrait transformer le diagnostic précoce et la gestion de la maladie, améliorant ainsi considérablement la qualité de vie des patients. Ce projet ambitieux est mené par une équipe pluridisciplinaire d'experts : 👉 Le Pr Julien Dumurgier, du Centre de neurologie cognitive de l'hôpital Lariboisière, AP-HP, sera responsable du recrutement et du suivi des patients. 👉 Le Dr Gilles Huberfeld, chef du programme d'épilepsie de l'adulte, du service d'EEG et de sommeil de l'Hôpital Fondation Adolphe de Rothschild, réalisera les évaluations EEG cruciales, aussi bien à l'hôpital qu'au domicile des patients. Ce projet a reçu une bourse prestigieuse de France Alzheimer et démarrera dans le courant de l'année. Nous avons hâte de voir l'impact de cette collaboration sur l'amélioration de la vie des personnes vivant avec la maladie d'Alzheimer. Cliquez sur "+Suivre" en haut de la page pour suivre l'évolution de cette recherche ! En savoir plus : www.naox.tech www.francealzheimer.org #épilepsie #alzheimer #innovation #sommeil #santé #MedTech #technologie #recherche #NaoX #Medicine4P #Neurophysiologie #Télémédecine

⚡ Spikes, Spikes, Spikes: Advancing Ambulatory Epilepsy Assessment & Monitoring with NaoX ear-EEG 👩⚕️ When it comes to diagnosing epilepsy, clinicians usually seek for Interictal Epileptiform Discharges (IEDs) on EEGs, those small electrical "spikes" that appear between seizures. While seizure detection is a frequent focus of wearable EEG devices, capturing these crucial IEDs is a highly valuable indicator, helping clinicians establish a diagnosis, in addition to the clinical background. Moreover this is the promise of epilepsy monitoring, which is currently impossible due to the bottleneck of EEG access. This is precisely what our latest research, presented by Dr. Jan Pyrzowski at the Mobile Health and Digital Technology in Epilepsy (MHDTE) conference in Copenhagen, has demonstrated. Our study, soon to be detailed in an upcoming publication, shows that our NaoX ear-EEG technology can reliably detect these IEDs. The data is compelling: 👉 Out of 4,454 IEDs analyzed, our in-ear device reliably detected individual IEDs, showing a strong correlation with traditional scalp EEG in most patients. 👉 Crucially, the qualitative features of the IEDs, such as their shape and signal-to-noise ratio, were preserved in the in-ear signals. This means that the visual cues/patterns clinicians rely on for diagnosis are maintained, making our device a powerful tool for visual detection. This study confirms that the NaoX ear-EEG, with its convenience, portability, and ability to perform extended, at-home recordings, is a valuable new tool for ambulatory epilepsy assessment and monitoring. What's Next? These thousands of IEDs, along with tens of thousands more we'll collect from ongoing clinical evaluations, will be used to train powerful AI algorithms. This will help us build a tool that will assist clinicians in the future, making epilepsy diagnosis faster and more accessible. And then step-in the seizure forecasting exciting field. So, we ask you: in your clinical practice, which is more helpful, and at which step, the seizure or the spikes? What would you like NaoX to capture on ambulatory EEG? www.naox.tech #epilepsy #EEG #wearable #MedTech #research #neurology #AI #MHDTE

New Research: Screening for Silent Temporal Lobe Epilepsy in Alzheimer's Disease Using NaoX Ear-EEG at Home. We are pleased to announce a significant research project that aims to advance our understanding and management of Alzheimer's Disease (AD).` Two leading hospitals in Paris are joining forces to investigate a critical, often overlooked connection: the prevalence of Temporal Lobe Epilepsy (TLE) during sleep in Alzheimer's patients. Emerging evidence suggests this can affect up to 30% or more of AD patients and significantly accelerate cognitive decline. Imagine the impact if we could easily identify and treat this! This vital research will explore the potential of NaoX ear-EEG as the first easy-to-use screening device for silent TLE in AD patients during sleep. This innovative approach could revolutionize early detection and AD management, significantly impacting patient outcomes. We're proud to see a multidisciplinary team of experts leading this charge: > Professor Julien Dumurgier from the Cognitive Neurology Center, Lariboisiere hospital, AP-HP, Assistance Publique - Hôpitaux de Paris, will be recruiting and following up with patients, > Gilles Huberfeld, MD, PhD, Head of program of the Adult Epilepsy, EEG and Sleep department at Hôpital Fondation Adolphe de Rothschild de Rothschild hospital, will be performing the essential EEG assessments, both in the hospital and in patients' homes. This ambitious project has been awarded a prestigious grant by France Alzheimer and is set to kick off later this year. We can't wait to see the impact of this collaborative effort on improving the lives of individuals living with Alzheimer's. Stay tuned for updates as this research progresses! www.naox.tech #epilepsy #alzheimer #sleep #innovation #health #MedTech #research #NaoX #4PMedicine #Neurophysiology #Telemedecine #EEG #RemotePatientMonitoring